Reduction of adhesions after uterine myomectomy by Seprafilm* membrane (HAL-F): a blinded, prospective, randomized, multicenter clinical study †‡*Seprafilm, Genzyme Corporation, Cambridge, Massachusetts.†Sponsored by Genzyme Corporation, Cambridge, Massachusetts.‡Presented in part at the Fourth Congress of the Society for Gynecological Endoscopy, Brussels, Belgium, December 6 to 9, 1995.
Fertility and Sterility, 1996, 66, 904-910